References

  1. Albers-Schonberg: Rontgenbilder einer seltenen Knockenerkrankung.

    Munch Med Wochenschr 1904 , 5:365-368. OpenURL

  2. Superti-Furga A US, and the Nosology Group of the International Skeletal Dysplasia Society: Nosology and Classification of Genetic Skeletal Disorders: 2006 Revision.

    American Journal of Medical Genetics Part A 2007 , 143A:1-18. Publisher Full Text OpenURL

  3. Loria-Cortes R, Quesada-Calvo E, Cordero-Chaverri C: Osteopetrosis in children: a report of 26 cases.

    J Pediatr 1977 , 91:43-47. PubMed Abstract | Publisher Full Text OpenURL

  4. Bollerslev J, Andersen PE Jr: Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis.

    Bone 1988 , 9:7-13. PubMed Abstract | Publisher Full Text OpenURL

  5. Al-Tamimi YZ, Tyagi AK, Chumas PD, Crimmins DW: Patients with autosomal-recessive osteopetrosis presenting with hydrocephalus and hindbrain posterior fossa crowding.

    J Neurosurg Pediatrics 2008 , 1:103-106. Publisher Full Text OpenURL

  6. Dozier TS, Duncan IM, Klein AJ, Lambert PR, Key LL Jr: Otologic manifestations of malignant osteopetrosis.

    Otol Neurotol 2005 , 26:762-766. PubMed Abstract | Publisher Full Text OpenURL

  7. Maranda B, Chabot G, Decarie JC, Pata M, Azeddine B, Moreau A, Vacher J: Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis.

    J Bone Miner Res 2008 , 23:296-300. PubMed Abstract | Publisher Full Text OpenURL

  8. Steward CG: Neurological aspects of osteopetrosis.

    Neuropathol Appl Neurobiol 2003 , 29:87-97. PubMed Abstract | Publisher Full Text OpenURL

  9. Alroy J, Pfannl R, Ucci A, Lefranc G, Frattini A, Megarbane A: Electron microscopic findings in skin biopsies from patients with infantile osteopetrosis and neuronal storage disease.

    Ultrastruct Pathol 2007 , 31:333-338. PubMed Abstract | Publisher Full Text OpenURL

  10. Jacquemin C, Mullaney P, Svedberg E: Marble brain syndrome: osteopetrosis, renal acidosis and calcification of the brain.

    Neuroradiology 1998 , 40:662-663. PubMed Abstract | Publisher Full Text OpenURL

  11. Whyte MP: Carbonic anhydrase II deficiency.

    Clin Orthop Relat Res 1993 , 52-63. PubMed Abstract | Publisher Full Text OpenURL

  12. Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, Moratto D, Mazzolari E, Clayton-Smith J, Orchard P, et al.: Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.

    Am J Hum Genet 2008 , 83:64-76. PubMed Abstract | Publisher Full Text OpenURL

  13. Kilic SS, Etzioni A: The Clinical Spectrum of Leukocyte Adhesion Deficiency (LAD) III due to Defective CalDAG-GEF1.

    J Clin Immunol 2008. PubMed Abstract | Publisher Full Text OpenURL

  14. Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhan GI, Gershoni-Baruch R, Etzioni A, Alon R: Kindlin-3: a new gene involved in the pathogenesis of LAD-III.

    Blood 2008 , 112:2591. PubMed Abstract | Publisher Full Text OpenURL

  15. Benichou OD, Laredo JD, de Vernejoul MC: Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): clinical and radiological manifestations in 42 patients.

    Bone 2000 , 26:87-93. PubMed Abstract | Publisher Full Text OpenURL

  16. Maroteaux P, Lamy M: [Pyknodysostosis.].

    Presse Med 1962 , 70:999-1002. PubMed Abstract OpenURL

  17. Maroteaux P, Lamy M: The Malady of Toulouse-Lautrec.

    Jama 1965 , 191:715-717. PubMed Abstract OpenURL

  18. Bartsocas CS: Pycnodysostosis: Toulouse-Lautrec's and Aesop's disease?

    Hormones (Athens) 2002 , 1:260-262. PubMed Abstract | Publisher Full Text OpenURL

  19. Edelson JG, Obad S, Geiger R, On A, Artul HJ: Pycnodysostosis. Orthopedic aspects with a description of 14 new cases.

    Clin Orthop Relat Res 1992 , 263-276. PubMed Abstract | Publisher Full Text OpenURL

  20. Muto T, Michiya H, Taira H, Murase H, Kanazawa M: Pycnodysostosis. Report of a case and review of the Japanese literature, with emphasis on oral and maxillofacial findings.

    Oral Surg Oral Med Oral Pathol 1991 , 72:449-455. PubMed Abstract | Publisher Full Text OpenURL

  21. Jones CM, Rennie JS, Blinkhorn AS: Pycnodysostosis. A review of reported dental abnormalities and a report of the dental findings in two cases.

    Br Dent J 1988 , 164:218-220. PubMed Abstract | Publisher Full Text OpenURL

  22. Soliman AT, Ramadan MA, Sherif A, Aziz Bedair ES, Rizk MM: Pycnodysostosis: clinical, radiologic, and endocrine evaluation and linear growth after growth hormone therapy.

    Metabolism 2001 , 50:905-911. PubMed Abstract | Publisher Full Text OpenURL

  23. Baker RK, Wallach S, Tashjian AH Jr: Plasma calcitonin in pycnodysostosis: intermittently high basal levels and exaggerated responses to calcium and glucagon infusions.

    J Clin Endocrinol Metab 1973 , 37:46-55. PubMed Abstract OpenURL

  24. Spranger J, Albrecht C, Rohwedder HJ, Wiedemann HR: [Dysosteosclerosis – a special form of generalized osteosclerosis].

    Fortschr Geb Rontgenstr Nuklearmed 1968 , 109:504-512. PubMed Abstract OpenURL

  25. Elcioglu NH, Vellodi A, Hall CM: Dysosteosclerosis: a report of three new cases and evolution of the radiological findings.

    J Med Genet 2002 , 39:603-607. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  26. Ghai S, Sharma R, Ghai S: Mixed sclerosing bone dysplasia – a case report with literature review.

    Clin Imaging 2003 , 27:203-205. PubMed Abstract | Publisher Full Text OpenURL

  27. Butkus CE, Michels VV, Lindor NM, Cooney WP 3rd: Melorheostosis in a patient with familial osteopoikilosis.

    Am J Med Genet 1997 , 72:43-46. PubMed Abstract | Publisher Full Text OpenURL

  28. Debeer P, Pykels E, Lammens J, Devriendt K, Fryns JP: Melorheostosis in a family with autosomal dominant osteopoikilosis: report of a third family.

    Am J Med Genet A 2003 , 119A:188-193. PubMed Abstract | Publisher Full Text OpenURL

  29. Nevin NC, Thomas PS, Davis RI, Cowie GH: Melorheostosis in a family with autosomal dominant osteopoikilosis.

    Am J Med Genet 1999 , 82:409-414. PubMed Abstract | Publisher Full Text OpenURL

  30. Voorhoeve N: L'image radiologique non encore decrit d'une anomalie du squelette; ses rapports avec la dyschondroplasie et l'osteopathia condensans disseminata.

    Acta Radiol 1924 , 3:407-427. Publisher Full Text OpenURL

  31. Savarirayan R, Nance J, Morris L, Haan E, Couper R: Osteopathia striata with cranial sclerosis: highly variable phenotypic expression within a family.

    Clin Genet 1997 , 52:199-205. PubMed Abstract OpenURL

  32. Manolagas SC: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.

    Endocr Rev 2000 , 21:115-137. PubMed Abstract | Publisher Full Text OpenURL

  33. Walker DG: The classic: Osteopetrosis cured by temporary parabiosis.

    Clin Orthop Relat Res 1982 , 2-3. PubMed Abstract | Publisher Full Text OpenURL

  34. Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, et al.: X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.

    Nat Genet 2001 , 27:277-285. PubMed Abstract | Publisher Full Text OpenURL

  35. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.

    Nature 1990 , 345:442-444. PubMed Abstract | Publisher Full Text OpenURL

  36. Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, et al.: Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL.

    Nat Genet 2007 , 39:960-962. PubMed Abstract | Publisher Full Text OpenURL

  37. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ: Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

    Cell 2001 , 104:205-215. PubMed Abstract | Publisher Full Text OpenURL

  38. Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, et al.: Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis.

    Nat Genet 2000 , 25:343-346. PubMed Abstract | Publisher Full Text OpenURL

  39. Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T, Hasan C, Bode U, Jentsch TJ, Kubisch C: Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis.

    Hum Mol Genet 2000 , 9:2059-2063. PubMed Abstract | Publisher Full Text OpenURL

  40. Li YP, Chen W, Liang Y, Li E, Stashenko P: Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.

    Nat Genet 1999 , 23:447-451. PubMed Abstract | Publisher Full Text OpenURL

  41. Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, Andolina M, Babul-Hirji R, Baric I, Canham N, Chitayat D, et al.: The mutational spectrum of human malignant autosomal recessive osteopetrosis.

    Hum Mol Genet 2001 , 10:1767-1773. PubMed Abstract | Publisher Full Text OpenURL

  42. Kasper D, Planells-Cases R, Fuhrmann JC, Scheel O, Zeitz O, Ruether K, Schmitt A, Poet M, Steinfeld R, Schweizer M, et al.: Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.

    Embo J 2005 , 24:1079-1091. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  43. Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, et al.: Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.

    Hum Mol Genet 2001 , 10:2861-2867. PubMed Abstract | Publisher Full Text OpenURL

  44. Lange PF, Wartosch L, Jentsch TJ, Fuhrmann JC: ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function.

    Nature 2006 , 440:220-223. PubMed Abstract | Publisher Full Text OpenURL

  45. Chalhoub N, Benachenhou N, Vacher J: Physical and transcriptional map of the mouse Chromosome 10 proximal region syntenic to human 6q16-q21.

    Mamm Genome 2001 , 12:887-892. PubMed Abstract | Publisher Full Text OpenURL

  46. Ramirez A, Faupel J, Goebel I, Stiller A, Beyer S, Stockle C, Hasan C, Bode U, Kornak U, Kubisch C: Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis.

    Hum Mutat 2004 , 23:471-476. PubMed Abstract | Publisher Full Text OpenURL

  47. Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE: Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.

    Proc Natl Acad Sci USA 1983 , 80:2752-2756. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  48. Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W: Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.

    J Bone Miner Res 2006 , 21:1399-1408. PubMed Abstract | Publisher Full Text OpenURL

  49. Troen BR: The regulation of cathepsin K gene expression.

    Ann N Y Acad Sci 2006 , 1068:165-172. PubMed Abstract | Publisher Full Text OpenURL

  50. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA: Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification.

    J Biol Chem 1996 , 271:12517-12524. PubMed Abstract | Publisher Full Text OpenURL

  51. Votta BJ, Levy MA, Badger A, Bradbeer J, Dodds RA, James IE, Thompson S, Bossard MJ, Carr T, Connor JR, et al.: Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo.

    J Bone Miner Res 1997 , 12:1396-1406. PubMed Abstract | Publisher Full Text OpenURL

  52. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K: Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.

    Proc Natl Acad Sci USA 1998 , 95:13453-13458. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  53. Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, et al.: Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization.

    J Bone Miner Res 1999 , 14:1654-1663. PubMed Abstract | Publisher Full Text OpenURL

  54. Gelb BD, Shi GP, Chapman HA, Desnick RJ: Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.

    Science 1996 , 273:1236-1238. PubMed Abstract | Publisher Full Text OpenURL

  55. Johnson MR, Polymeropoulos MH, Vos HL, Ortiz de Luna RI, Francomano CA: A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis.

    Genome Res 1996 , 6:1050-1055. PubMed Abstract | Publisher Full Text OpenURL

  56. Van Wesenbeeck L, Odgren PR, Coxon FP, Frattini A, Moens P, Perdu B, MacKay CA, Van Hul E, Timmermans JP, Vanhoenacker F, et al.: Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans.

    J Clin Invest 2007 , 117:919-930. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  57. van Wesenbeeck L, Odgren PR, Mackay CA, Van Hul W: Localization of the gene causing the osteopetrotic phenotype in the incisors absent (ia) rat on chromosome 10q32.1.

    J Bone Miner Res 2004 , 19:183-189. PubMed Abstract | Publisher Full Text OpenURL

  58. Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJ, et al.: Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis.

    Nat Genet 2004 , 36:1213-1218. PubMed Abstract | Publisher Full Text OpenURL

  59. Hellemans J, Debeer P, Wright M, Janecke A, Kjaer KW, Verdonk PC, Savarirayan R, Basel L, Moss C, Roth J, et al.: Germline LEMD3 mutations are rare in sporadic patients with isolated melorheostosis.

    Hum Mutat 2006 , 27:290. PubMed Abstract | Publisher Full Text OpenURL

  60. Grzeschik KH, Bornholdt D, Oeffner F, Konig A, del Carmen Boente M, Enders H, Fritz B, Hertl M, Grasshoff U, Hofling K, et al.: Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia.

    Nat Genet 2007 , 39:833-835. PubMed Abstract | Publisher Full Text OpenURL

  61. Wang X, Reid Sutton V, Omar Peraza-Llanes J, Yu Z, Rosetta R, Kou YC, Eble TN, Patel A, Thaller C, Fang P, Veyver IB: Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia.

    Nat Genet 2007 , 39:836-838. PubMed Abstract | Publisher Full Text OpenURL

  62. Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia-Minaur S, et al.: Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis.

    Nat Genet 2009 , 41:95-100. PubMed Abstract | Publisher Full Text OpenURL

  63. Waguespack SG, Hui SL, White KE, Buckwalter KA, Econs MJ: Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.

    J Clin Endocrinol Metab 2002 , 87:2212-2217. PubMed Abstract | Publisher Full Text OpenURL

  64. Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Vaananen HK, Halleen JM: Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).

    Clin Chem 2004 , 50:883-890. PubMed Abstract | Publisher Full Text OpenURL

  65. Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M, et al.: Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.

    J Med Genet 2006 , 43:315-325. PubMed Abstract | Publisher Full Text OpenURL

  66. Ogur G, Ogur E, Celasun B, Baser I, Imirzalioglu N, Ozturk T, Alemdaroglu A: Prenatal diagnosis of autosomal recessive osteopetrosis, infantile type, by X-ray evaluation.

    Prenat Diagn 1995 , 15:477-481. PubMed Abstract | Publisher Full Text OpenURL

  67. Landa J, Margolis N, Di Cesare P: Orthopaedic management of the patient with osteopetrosis.

    J Am Acad Orthop Surg 2007 , 15:654-662. PubMed Abstract | Publisher Full Text OpenURL

  68. Hwang JM, Kim IO, Wang KC: Complete visual recovery in osteopetrosis by early optic nerve decompression.

    Pediatr Neurosurg 2000 , 33:328-332. PubMed Abstract | Publisher Full Text OpenURL

  69. Driessen GJ, Gerritsen EJ, Fischer A, Fasth A, Hop WC, Veys P, Porta F, Cant A, Steward CG, Vossen JM, et al.: Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report.

    Bone Marrow Transplant 2003 , 32:657-663. PubMed Abstract | Publisher Full Text OpenURL

  70. Steward CG, Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A, Lang D, Fischer A, Friedrich W, Schulz AS: Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis.

    Br J Haematol 2004 , 124:63-71. PubMed Abstract | Publisher Full Text OpenURL

  71. Frattini A, Blair HC, Sacco MG, Cerisoli F, Faggioli F, Cato EM, Pangrazio A, Musio A, Rucci F, Sobacchi C, et al.: Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero.

    Proc Natl Acad Sci USA 2005 , 102:14629-14634. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  72. Key LL Jr, Ries WL, Rodriguiz RM, Hatcher HC: Recombinant human interferon gamma therapy for osteopetrosis.

    J Pediatr 1992 , 121:119-124. PubMed Abstract | Publisher Full Text OpenURL

  73. Key LL Jr, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, Cure JK, Griffin PP, Ries WL: Long-term treatment of osteopetrosis with recombinant human interferon gamma.

    N Engl J Med 1995 , 332:1594-1599. PubMed Abstract | Publisher Full Text OpenURL

  74. Kocher MS, Kasser JR: Osteopetrosis.

    Am J Orthop 2003 , 32:222-228. PubMed Abstract OpenURL

  75. Key L, Carnes D, Cole S, Holtrop M, Bar-Shavit Z, Shapiro F, Arceci R, Steinberg J, Gundberg C, Kahn A, et al.: Treatment of congenital osteopetrosis with high-dose calcitriol.

    N Engl J Med 1984 , 310:409-415. PubMed Abstract OpenURL

  76. Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C: Infantile Malignant, Autosomal Recessive Osteopetrosis: The Rich and The Poor.

    Calcif Tissue Int 2008. PubMed Abstract | Publisher Full Text OpenURL

  77. Del Fattore ACA, Teti A: Genetics, pathogenesis and complications of osteopetrosis.

    Bone 2008 , 42:19-29. PubMed Abstract | Publisher Full Text OpenURL